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A commentary on
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cific antigenic stimuli
by Oppenheim JJ, Leventhal BG, Hersh EM.
J Immunol (1968) 101:262–70.
This contribution to the project on the
Living History of Immunology concerning
“The Transformation of Column-Purified
Lymphocytes with Non-specific and Spe-
cific Antigenic Stimuli,” by Joost J. Oppen-
heim, Brigid G. Leventhal, and Evan M.
Hersh represents another excellent exam-
ple of research based on a serendipitous
discovery snatched from the jaws of a failed
project (1). Evan, Brigid, and I were all
clinical associates at the NCI engaged in
the care of patients with leukemia and
solid tumors from 1962 until 1965. As a
reward for our clinical efforts, we were
given the opportunity to pursue laboratory
research studies with one of the principal
investigators for the last 2 years of our stay.
Following several false starts, I ended
up in the laboratory of Dr. Jacque-
line Wang Peng, who was an expert
in studies of chromosome abnormalities
caused by neoplastic changes and dam-
age from chemotherapeutic and radia-
tion treatments. Our chromosome analyses
were frustrated by the failure of leukemic
lymphocytes from chronic lymphocytic
leukemia (CLL) patients to be activated to
divide and develop metaphases that could
be analyzed for chromosome breaks in
response to a kidney bean extract known
as phytohemagglutinin (PHA). Since the
peripheral blood (PB) of more advanced
CLL patients contained high numbers of
white blood cells (WBC) consisting entirely
of lymphocytes, we decided as a control
to purify the non-adherent lymphocytes
present in normal PBWBC by eluting them
off sterile glass bead or nylon fiber columns,
which retained the adherent phagocytic
neutrophils and monocytes.
After numerous mishaps and consider-
able practice, these columns yielded at least
98% pure lymphocytes based on micro-
scopic analysis. We were dismayed to find
that these purified normal lymphocytes
were also hyporesponsive to a variety of
antigenic stimulants such as tetanus toxoid
and streptolysin O, but still showed normal
proliferative response to the more potent
polyclonal PHA stimulant. This was deter-
mined from the proportion of cells under-
going morphological blastogenesis and the
uptake of tritiated thymidine. However,
the purified lymphocytes in comparison
with unpurified normal lymphocytes were
also hyporesponsive to suboptimal doses
of PHA. Of course, we were very con-
cerned that the column procedure had
damaged the cells, but we failed to observe
any evidence of cell death based on try-
pan blue uptake. Furthermore, when cul-
tured at a higher cell density, the lympho-
proliferative response to antigens showed
some recovery arguing against cell damage.
This observation also suggested the possi-
bility that the few residual contaminating
non-lymphocytic cells might be interact-
ing more effectively over the shorter dis-
tances at higher cell densities. We tested
this idea by adding some unfractionated
WBC back to the cultures of purified lym-
phocytes, which partially restored the lym-
phoproliferative response to antigens. A
feeder layer consisting of WI-38 human
embryonic fibroblasts had no restorative
effect.
These results unfortunately failed to
shed any light on the unresponsiveness
of CLL cells. However, they pointed to
the requirement for a cooperative inter-
action between phagocytic cells and lym-
phocytes. Based on the available literature,
we proposed that macrophages were some-
how facilitating the activation of lympho-
cytes to “transform” and proliferate. Evan
Hersh and Jules Harris obtained convinc-
ing evidence in support of this hypoth-
esis by restoring the lymphoproliferative
responses by the addition of coverslips
with adherent human macrophages to the
cultures of purified lymphocytes (2).
I further pursued my immunological
studies during a sabbatical year at the Uni-
versity of Birmingham in England from
1965 to 1966, where I learned to work with
non-human species and showed that puri-
fied lymphocytes from guinea pig lymph
nodes were also unresponsive to antigenic
stimulants unless supplemented with some
phagocytic cells. Upon returning to the
Dental Institute at the National Institutes
of Health (NIH), I was joined by a pedia-
trician, Dr. Robert Seeger in investigations
of the role of macrophages in immunity.
We were able to show that footpad injec-
tion of peritoneal macrophages from syn-
geneic guinea pigs after a brief exposure
to antigens such as ovalbumin induced
greater delayed hypersensitivity (DTH)
reactions and were better at priming anti-
body responses than equal or higher doses
of soluble antigens (3). Furthermore, anti-
gens were taken up much less well by lym-
phocytes, thymocytes, and hepatoma cells
than to macrophages and these cells were
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not immunogenic (4). Thus, macrophages
could activate T lymphocytes to mediate
DTH and prime B-cell antibody produc-
tion. Bob Seeger and I also determined that
peritoneal, alveolar, or PB macrophages
obtained from either immune or non-
immune donors were all equally effective
at priming immune responses (5). How-
ever, macrophages could not induce non-
immune lymphocytes to proliferate. Thus
immune specificity and memory appeared
to be a property of lymphocytes rather than
macrophages.
In the course of our studies, Bob
and I noticed that syngeneic macrophages
were much more effective than allo-
geneic macrophages, but we did not pur-
sue this issue. Alan Rosenthal thoroughly
investigated the role of histocompatibil-
ity in this interaction. Alan Rosenthal
and Ethan Shevach went on to show that
the macrophage–lymphocyte interactions
required MHC compatibility to be suc-
cessful (6). They further determined, using
alloantisera against MHC antigens, that
macrophage MHC was necessary for T
lymphocytic recognition of antigens (7).
Of course, Ralph Steinman’s discovery
that dendritic cells (DC) contaminating
the macrophage preparations were actu-
ally the most potent antigen presenting
cells superseded our findings (8). How-
ever, I must confess that I found it diffi-
cult to accept the idea that the small con-
taminant population of DC rather than
macrophages was responsible for antigen
presentation, until this became incontro-
vertible based on the in vitro studies of
Jacques Banchereau and his colleagues (9).
They were able to produce large num-
bers of dendritic/Langerhans cells in vitro
by culturing cord blood hematopoietic
progenitor cells with a combination of
granulocyte-macrophage colony stimulat-
ing factor and tumor necrosis factor. These
cells had the morphology and phenotypic
markers of DC and were very potent at
presenting antigens and priming T lym-
phocytes.
Our serendipitous finding that T cells
require accessory cells for antigen presen-
tation was based on an initial desire to
better understand the failure of lympho-
cytes from CLL patients to transform in
response to stimulation. Other investiga-
tors have determined that CLL cells are usu-
ally monoclonal B lymphocytes that do not
respond to T cell stimulants (10). This was
followed by curiosity on our part to better
understand the inability of purified normal
peripheral human lymphocytes to respond
to antigenic stimulation unless supple-
mented by macrophages. Our observations
led other investigators to discover the cru-
cial role of MHC in antigen presentation,
antigen processing, and the outstanding
capacity of DC to activate T cell-dependent
immune responses. These consequent find-
ings went beyond the scope of our imagi-
nation. In conclusion, our unexpected sci-
entific findings clearly contributed in an
unanticipated manner to a greater under-
standing of adaptive immunity and clearly
illustrate the stepwise communal process of
scientific progress.
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